[1]
E. Ertan and M. Doğan, “Neovascular age-related macular degeneration: 18-month outcomes of aflibercept treatment in patients resistant to ranibizumab”, Eur Res J, vol. 5, no. 6, pp. 977–980, Nov. 2019, doi: 10.18621/eurj.446300.